Document:

Exhibit
4.9

 

	[stamp]
                                            State of Israel

    Israeli
    Medical

    Cannabis
    Agency

    (IMCA)
	 	[logo]
                                            [emblem of the State of Israel]

    Ministry

    of
    Health

    [illegible]

    Medical
    Cannabis Agency

    Expiry Date: October 12, 2021

    

    Dealer’s Code: V-1315-060518

 

Initial
Authorization for Establishing a Site for Dealing with a Controlled Substance

 

By
virtue of the authority vested in me pursuant to the middle of Sections 6, 13-17 of the Dangerous Drugs [New Version] Ordinance, 5733
– 1973 (hereinafter: “the Ordinance”) and pursuant to the Dangerous Drugs Regulations, 5740 – 1979 (hereinafter:
“the Regulations”), an initial authorization to establish a Proliferation Farm – Cannabis Plant Proliferation (hereinafter:
“the site”) has been granted, pursuant to the following details:

 

	1.	The
                                            Applicant for the Authorization and his Details:

 

	 	1.1
                                                         Entrepreneur/Corporation’s Name: Dalia Brzezinski

    1.2
Site Address: Kochav Michael

    1.3
    Contact Person (Name): Dalia Brzezinski
	ID/Pvt.
                                            Co. No: 054771613 (hereinafter: “the Applicant”)

    Farm/Estate
    Farm No 10

    Waypoint

    ID
    No: 054771613 Tel No: 054-222-8861

 

	2.	Name
                                            of the Controlled Substance:

 

Cannabis

 

	3.	Its
                                            Form:

 

This
authorization does not constitute authorization to hold in any form.

 

It
is absolutely prohibited to hold the drug, plant, parts of it, its ingredients, or products and in any form, as long as no express license
for this has been received from the Director.

 

	4.	The
                                            Objective of the Authorization:

 

		4.1	To
                                            work toward planning/establishing/adapting a proliferation farm – cannabis plant proliferation
	 	 	 
		4.2	The
                                            Applicant declares that this authorization will not be used for any purpose not authorized
                                            and specified explicitly in this authorization.

 

	5.	Restrictions
                                            and Additional Conditions

 

		5.1	This
                                            authorization is only temporary. This authorization can be annulled at the Director’s
                                            sole discretion, or pursuant to a decision of the Government of Israel, without derogating
                                            from any other cause in the law for annulling the authorization.
	 	 	 
		5.2	This
                                            authorization contains nothing to impose any obligation whatsoever on the Ministry of Health
                                            or the Medical Cannabis Agency to grant a license for dealing in a controlled substance.
	 	 	 
		5.3	This
                                            authorization is authorization for the Applicant to commence establishing or adapting the
                                            site according to the planned occupation. The principles of the planning and establishment/adaptation
                                            of the business must be accomplished according to the intended occupation, while complying
                                            with all the relevant requirements of the law and pursuant to the quality and security requirements
                                            as detailed below:
	 	 	 

		a.	Cultivation
                                            or proliferation of cannabis plants – as detailed in the IMC-GAP Procedure (Suitable
                                            Cultivation Conditions) and as detailed in the IMC-GSP Procedure (Security Conditions).

 

It
must be emphasized that the Applicant must comply with the security requirements at the site as detailed in the IMC-GCP Procedure and
receive security confirmation pursuant to the type of occupation.

 

		5.4	This
                                            authorization is non-transferable in any form whatsoever.
	 	 	 
		5.5	Should
                                            there be any change whatsoever in the ownership of the Applicant, or in the identification
                                            of the controlling shareholders, managers or authorized signatories on its behalf, which
                                            are detailed in this license, without receiving the IMCA’s advance written approval
                                            for this, the validity of this license shall expire. Regarding this Section, a change in
                                            the ownership means transfer of shares in any manner whatsoever, in a volume that exceeds
                                            5% of the company’s total shares.
	 	 	 
		5.6	In
                                            view of operations in the cannabis field, and because these operations necessitate, inter
                                            alia, receipt of authorizations and/or licenses pursuant to the details in the Government’s
                                            Resolution 1587 Section 3a from the IMCA, including receipt of the IMCA’s authorization
                                            for all the dealers, managers and controlling shareholders in companies and/or their managers
                                            – the authorization is subject to the conditions hereto attached
	 	 	 

		a.	Every
                                            material shareholder as defined in the Companies Law, 5759 – 1999 and/or interested
                                            party as defined in the Companies Law, 5759 – 1999 and/or an effective interested party*and/or
                                            director and/or general manager in the company has to receive the IMCA’s authorization.

 

[signature]

[stamp] Mgr Yuval Landschaft

L.N. 4023

 

The
Medical Cannabis Agency (IMCA) 

	Israeli
                                            Medical Cannabis Agency

    Minister
    of Health

    PO
    Box 1176, Jerusalem 91010

    IMCA@moh.health.gov.il

    Tell
    No: *5400 Fax No: 02-647-4810
	 	Health
                                            Answering Service

    *5400
	 	[bilingual
    text see left column]

 

    	 

    	 

    

 

	[stamp]
                                            State of Israel

    Israeli
    Medical

    Cannabis
    Agency

    (IMCA)
	 	[logo]
                                            [emblem of the State of Israel]

    Ministry

    of
    Health

    [illegible]

    Medical
    Cannabis Agency

    Expiry Date: October 12, 2021

    

    Dealer's Code: V-1315-060518

 

		b.	No
                                            shares in the company may be allotted to any offeree whatsoever, which, following this allocation,
                                            will convert him into a material shareholder and/or interested party and/or effective interested
                                            party*, prior to receiving the IMCA’s approval for this.
	 	 	 
		c.	No
                                            director and/or general manager in the company may be appointed prior to receiving the IMCA’s
                                            approval for this.
	 	 	 
		d.	The
                                            company must amend the Company’s Articles Association so that they include an instruction,
                                            pursuant to which, if any entity/entities whatsoever become material shareholders and/or
                                            interested parties and/or effective interested parties*in the company by virtue of holding
                                            its shares or agreement between shareholders, prior to receiving the mandatory authorizations
                                            from the IMCA, the company shall have the right to forfeit shares and/or anesthetize some
                                            of the shares held by one or more of these shareholders, so that after the forfeiture and/or
                                            anesthetization of the shares, there will not be any interested party entities by virtue
                                            of holdings or by virtue of agreement or effective interested parties*in the company.
	 	 	 
		e.	The
                                            company must not extend the tenure of a director or its general manager, unless there is
                                            IMCA approval regarding him on the date of the extension.
	 	 	 
		f.	At
                                            any Annual Meeting of the company the general manager of the company must declare that all
                                            the mandatory IMCA authorizations for the company and dealer/dealers, manager/managers and
                                            interested party/parties as detailed in Sections a. b. and c. above exist and are valid on
                                            the date of the meeting and that there has not been any change in the status of the dealer/dealers,
                                            manager/managers, material shareholder/shareholders and interested party/parties from the
                                            time of granting the authorization/authorizations.

 

*
An effective interested party is a controlling interest in the interested party and/or a material shareholder as these are defined in
the Companies Law, 5759 – 1999.

 

		5.7	The
                                            Applicant must inform the Director immediately of any change in any of his details (address,
                                            contact person’s etc.) and receive the IMCA’s advance written approval for any
                                            change in the ownership of the Applicant or in the identity of the interested parties in
                                            it or its managers or its authorized signatories or the material shareholders.
	 	 	 
		5.8	The
                                            presence of minors at the site or in its installations is absolutely prohibited.
	 	 	 
		5.9	The
                                            provisions in the Ordinance and Regulations and any instruction and stipulation for complying
                                            with any mandatory quality conditions apply to the Applicant.
	 	 	 
		5.10	The
                                            Applicant must maintain regular records of all the operations regarding the establishment
                                            of the site and any additional record required by the Director. The records must be presented
                                            to the Director at any time that he demands this and must be presented to any other competent
                                            entity, according to the matter, according to the Director’s demand.
	 	 	 
		5.11	it
                                            will be possible to update the conditions and stipulations at the IMCA’s discretion
                                            and with the approval of the Dir. Gen. at the Health Ministry. The IMCA is entitled to publish
                                            additional instructions according to the circumstances and essence of the business.

 

	6.	The
                                            Validity of the Authorization:

 

		6.1	This
                                            authorization annuls any previous, other or additional authorization at the Applicant’s
                                            disposal
	 	 	 
		6.2	This
                                            authorization was granted today October 12, 2020 at the IMCA’s offices.
	 	 	 
		6.3	This
                                            authorization expires on October 12, 2021, unless annulled previously to this
                                            by the Director’s decision.

 

[signature]

[stamp]
Mgr Yuval Landschaft

L.N.
4023

Director

The
Medical Cannabis Agency IMCA

Yuval
Landschaft

Director
pursuant to the Dangerous Drugs Ordinance

 

The
Medical Cannabis Agency (IMCA)

	Israeli
                                            Medical Cannabis Agency

    Minister
    of Health

    PO
    Box 1176, Jerusalem 91010

    IMCA@moh.health.gov.il

    Tell
    No: *5400 Fax No: 02-647-4810
	 	Health
                                            Answering Service

    *5400
	 	[bilingual
    text see left column]Exhibit
4.10

 

TRUST
DECLARATION

 

THIS
DECLARATION made as of the 1st day of October, 2020.

 

WHEREAS
the undersigned is the registered owner of 260,000 ordinary shares (the “Trust Shares”) in the capital stock of
B.Y.B.Y. Investments and Promotions Ltd. (the “Corporation”);

 

AND
WHEREAS the Trust Shares represent 26% of the issued and outstanding shares of the Corporation.

 

NOW
THEREFORE THIS DEED WITNESSETH THAT:

 

1.
I, Dalya Bzizinsky, hereby declare and acknowledge that I hold title to the Trust Shares as bare trustee for and solely on behalf of
BYND - Beyond Solutions Ltd. (the “Beneficiary”) and I otherwise have no legal or beneficial interest in the
Trust Shares.

 

2.
I agree to hold the Trust Shares for and on behalf of the Beneficiary and to deal therewith only as directed by the
Beneficiary.

 

3.
I will do no act or thing, or institute any action or proceeding of any nature respecting the Trust Shares. The only act which I am
obliged to perform is to transfer the Trust Shares as directed by the Beneficiary.

 

4.
All benefits and burdens arising from the Trust Shares, including but not limited to dividends, including stock dividends and other
distributions, whether of capital or income, that may from time to time be payable on the Trust Shares belong legally and
beneficially to the Beneficiary and this Declaration shall act as a direction to the Corporation to make all such payments to the
Beneficiary.

 

5.
This Declaration shall be binding upon and enure to the benefit of my heirs, estate trustees, successors and assigns and the heirs,
estate trustees, successors and assigns of Beneficiary.

 

[remainder
of page intentionally left blank - signature page to follow]

 

    	 

    	 

    

 

IN
WITNESS WHEREOF I have hereto set my hand and seal as of the date first above written.

 

	IN
    THE PRESENCE OF:	 	)	 
	 	 	)	 
	 	 	)	 
	 	 	)	 
	 	 	)	“Dalia
    Brzezinski”
	Witness	 	)	Dalia
    Brzezinski
	 	 	)	 

 

The
Corporation hereby acknowledges the direction contained herein.

 

	 	B.Y.B.Y.
    INVESTMENTS AND PROMOTIONS LTD.
	 	 	 
	 	Per:	“Yftah
    Ben Yaackov” 
	 	 	Yftah
    Ben Yaackov, ASO

 

The
undersigned beneficial owner, having read the foregoing hereby acknowledges and agrees with the terms hereof.

 

	 	BYND
    – BEYOND SOLUTIONS LTD.
	 	 	 
	 	Per:	“Moti
    Maram”
	 	 	Moti
    Maram, President

 

    	2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}]]